Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469409

COc1ccc(OC)c2c(C)nc(Nc3nc(O)c4ccccc4n3)nc12.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.40
NPC1 O15118 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 2/20 0.38
NQO2 P16083 1/20 0.36
IGF1R P08069 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
RAD52 P43351 2/20 0.35
CDK9 P50750 1/20 0.35
DYRK1A Q13627 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6470297 0.94 KMT2A (0.41) KMT2AMEN1SMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL6470125 0.89 ABCG2 (0.41) KMT2AMEN1SMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL6469265 0.86 POLB (0.37) ALDH1A1POLBGAA
Trifluoroacetic Acid SCHEMBL6469512 0.86 KMT2A (0.43) KMT2AMEN1SMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL6467982 0.85 POLB (0.42) KMT2APOLBGAA
SCHEMBL6469411 0.84 KMT2A (0.41) KMT2AMEN1SMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL6467880 0.84 HDAC3 (0.46) KMT2AMEN1SMN1; SMN2TP53NPC1
Trifluoroacetic Acid SCHEMBL6465606 0.84 STAT3 (0.36) SMN1; SMN2TP53NPC1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6469497 0.83 WHR1 (0.40) KMT2AMEN1TP53ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6467878 0.81 KMT2A (0.47) KMT2AMEN1SMN1; SMN2TP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885MEN1 4218/4885SMN1; SMN2 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.